What is Chemed's market cap?

Chemed (CHE) has a market capitalization of $6.9B and trades on NYSE.

What is Chemed's revenue and profitability?

Chemed generated $2.6B in trailing twelve-month revenue with net income of $275.0M, representing a net margin of 10.6%. Gross margin stands at 33.1%, with free cash flow of $323.6M. These figures are based on the Q2 2026 filing.

Who are Chemed's competitors?

Chemed's key competitors include FirstService Corporation, The Pennant Group, Inc. Common Stock, Option Care Health, Inc. Common Stock, and others. These companies compete in similar markets and product categories.

What subsidiaries does Chemed have?

Chemed's subsidiaries include VITAS Healthcare, Roto-Rooter.

Where is Chemed headquartered?

Chemed is headquartered in United States of America and employs approximately 15,087 people. It has been publicly traded since 1972.

CHE

Chemed

CHE

Chemed Corporation is a diversified holding company that acquires and operates market-leading subsidiaries across distinct service industries.

Market cap

$6.87B+12.7%

Revenue$2.6B+3.3%

Net income$275.0M-5.3%

Free cash flow$323.6M-12.9%

EPS (diluted)$19.88+2.3%

Trailing twelve months · change vs. prior year

Table of contents

Earnings

Q2 2026 report

July 28, 2026

Revenue$673.3MBeat by $8.2M EPS$6.06Beat by $0.46

Read the full report

Next report

Oct 27, 2026 (in 3 months)

Revenue estimate$674.1M

EPS estimate$6.01

Financials

Q2 2026

Income statement

See full

Revenue$673.3M+8.8%

Gross profit$221.5M+19.9%

Operating income$89.2M+31.0%

Net income$67.7M+29.0%

EPS (diluted)$5.13+43.7%

Balance sheet

See full

Cash & equivalents$40.2M-83.9%

Total debt$181.3M+24.5%

Total equity$830.5M-30.7%

Total assets$1.6B-8.0%

Cash flow

See full

Operating cash flow$84.8M-38.8%

CapEx$15.5M-1.8%

Free cash flow$69.3M-43.6%

Valuation & ratios

Valuation

See full

Market cap$6.87B+12.7%

Enterprise value$7.01B+4.8%

P/E25×+1.6×

P/S2.7×-0.1×

Profitability

See full

Gross margin33.1%-0.5pp

Operating margin13.5%-1.2pp

Net margin10.6%-1.0pp

FCF margin12.5%-2.3pp

Returns & leverage

See full

Return on equity27.1%+3.0pp

Debt / equity0.2×+0.1×

Current ratio0.9×-1.0×

Competitors

By market cap

CHE

Chemed$6.9B+1.1%

FirstService Corporation$6.6B-26.4%

ICU Medical$4.1B+32.8%

National Healthcare$3.6B+141%

Option Care Health, Inc.$3.5B-28.5%

Addus HomeCare$2.2B+12.1%

Aveanna Healthcare Holdings Inc.$2.2B+160%

The Pennant Group, Inc.$1.5B+84.4%

By revenue growth

The Pennant Group, Inc.+36.8%

Aveanna Healthcare Holdings Inc.+20.5%

Addus HomeCare+19.6%

National Healthcare+10.3%

Option Care Health, Inc.+5.9%

CHE

Chemed+3.3%

ICU Medical-10.9%

By net margin

CHE

Chemed10.6%-1.0pp

Aveanna Healthcare Holdings Inc.10.37%+12.0pp

National Healthcare8.28%+0.5pp

Addus HomeCare6.89%+0.4pp

Option Care Health, Inc.3.68%-0.3pp

The Pennant Group, Inc.2.96%-0.4pp

ICU Medical-0.317%+7.0pp

Profile

Chemed Corporation is a diversified holding company that acquires and operates market-leading subsidiaries across distinct service industries. The company focuses on maximizing shareholder value through a decentralized management approach, providing strategic oversight and capital allocation to its primary operating units in the healthcare and residential services sectors.

Competitive position

Chemed maintains a dominant market position in both the hospice care sector through VITAS and the plumbing services industry through the nationally recognized Roto-Rooter brand.

GeographiesUnited States

Customer segmentsHealthcare patients, Residential homeowners, Commercial enterprises

Business modelService-based, Decentralized Holding Company, B2C, B2B

SuppliersMedical supply manufacturers, Pharmaceutical companies, Specialized plumbing equipment manufacturers, Vehicle fleet providers

CustomersIndividual patients and families, Residential property owners, Commercial businesses, Government healthcare programs

CountryUnited States of America

Listed1972

Employees15.1K

CEOKevin J. McNamara

SectorHealthcare

IndustryMedical - Care Facilities

Websitechemed.com

FilingsSEC EDGAR

Ask your AI about Chemed.

Connect your AI assistant and dig into the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Chemed's market cap?: Chemed (CHE) has a market capitalization of $6.9B and trades on NYSE.
What is Chemed's revenue and profitability?: Chemed generated $2.6B in trailing twelve-month revenue with net income of $275.0M, representing a net margin of 10.6%. Gross margin stands at 33.1%, with free cash flow of $323.6M. These figures are based on the Q2 2026 filing.
Who are Chemed's competitors?: Chemed's key competitors include FirstService Corporation, The Pennant Group, Inc. Common Stock, Option Care Health, Inc. Common Stock, and others. These companies compete in similar markets and product categories.
What subsidiaries does Chemed have?: Chemed's subsidiaries include VITAS Healthcare, Roto-Rooter.
Where is Chemed headquartered?: Chemed is headquartered in United States of America and employs approximately 15,087 people. It has been publicly traded since 1972.